2rounds
—led
Cybersecurity 1Proptech 1
Growth 1, Series C+ 1
Details
New companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
XBE Undisclosed GrowthHorizon3 $250M Series ELoading investors…
Loading investors…
Recent funding activity in US startups, organised by investor and their role in each round.
New companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
XBE Undisclosed GrowthHorizon3 $250M Series ENew companies 2 · Follow-on 0
Stages: Series C+ 2
Abcuro $66M Series DEpicrispr Biotechnologies $90M Series CNew companies 1 · Follow-on 1
Stages: Series B 1, Series C+ 1
Smack Technologies $61M Series BSkan AI $63M Series CNew companies 1 · Follow-on 1
Stages: Series B 2
Smack Technologies $61M Series BHeaviside Industries $60M Series BNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Abcuro $66M Series DKhartis Therapeutics $50M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Velaura AI $110M Series ALumilens >$700M Series CNew companies 1 · Follow-on 1
Stages: Series A 1, Series C+ 1
Velaura AI $110M Series AHorizon3 $250M Series ENew companies 2 · Follow-on 0
Stages: Series C+ 2
Abcuro $66M Series DEpicrispr Biotechnologies $90M Series CNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Smack Technologies $61M Series BHorizon3 $250M Series ENew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Velaura AI $110M Series ALumilens >$700M Series CNew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Abcuro $66M Series DBridge to Life $110M Series C+DebtNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Velaura AI $110M Series AMariana Minerals $310M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Leal Therapeutics $30M Series AKhartis Therapeutics $50M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Leal Therapeutics $30M Series AInduPro $77M Series BNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Higgsfield $400M Series BZenity $125M Series CNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Higgsfield $400M Series BCodeRabbit $143M Series CNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Khartis Therapeutics $50M Series BInfinimmune $75M Series ANew companies 1 · Follow-on 1
Stages: Seed 1, Series B 1
Heaviside Industries $60M Series BSoctera $4M SeedNew companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Thrive Holdings $2B GrowthBase Power $1B Series DNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Discovered Materials $9M SeedNaïve $28.5M Series ANew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Discovered Materials $9M SeedMitti Labs $9.5M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Flagler Health $50M Series BHorizon3 $250M Series E“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.